标题
Emerging therapeutic strategies to enhance HDL function
作者
关键词
-
出版物
Lipids in Health and Disease
Volume 10, Issue 1, Pages 175
出版商
Springer Nature
发表日期
2011-10-11
DOI
10.1186/1476-511x-10-175
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR-/- mice
- (2011) Dacheng Peng et al. BRITISH JOURNAL OF PHARMACOLOGY
- Seeking Novel Targets for Improving In Vivo Macrophage-Specific Reverse Cholesterol Transport: Translating Basic Science into New Therapies for the Prevention and Treatment of Atherosclerosis
- (2011) Josep Julve et al. Current Vascular Pharmacology
- ETC-216 for coronary artery disease
- (2011) Stephen J Nicholls et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- HDL/Apolipoprotein A-I Binds to Macrophage-Derived Progranulin and Suppresses its Conversion into Proinflammatory Granulins
- (2011) Hanayuki Okura et al. Journal of Atherosclerosis and Thrombosis
- Anti-oxidant properties of high-density lipoprotein and atherosclerosis
- (2010) Eugene A Podrez CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- High-density lipoproteins, platelets and the pathogenesis of atherosclerosis
- (2010) Jerzy-Roch Nofer et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial
- (2010) Evan A. Stein et al. EUROPEAN HEART JOURNAL
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
- (2009) David Masson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano
- (2009) Eric T. Alexander et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats
- (2009) ESG Stroes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community
- (2009) Ramachandran S. Vasan et al. CIRCULATION
- Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
- (2009) M. J. Chapman et al. EUROPEAN HEART JOURNAL
- Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function
- (2009) Justin M.S. Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients
- (2008) Daniel Bloomfield et al. AMERICAN HEART JOURNAL
- Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
- (2008) James A. Shaw et al. CIRCULATION RESEARCH
- Surrogate End Points and FDA Approval
- (2008) Bruce M. Psaty et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-IMilano
- (2008) Giovanni Cimmino et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Rapid Change in Plaque Size, Composition, and Molecular Footprint After Recombinant Apolipoprotein A-IMilano (ETC-216) Administration
- (2008) Borja Ibanez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo
- (2007) Rajesh Puranik et al. ATHEROSCLEROSIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started